Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
- Status
- COMPLETED
- Phase
- NA
A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT
- Status
- COMPLETED
- Phase
- PHASE2
ACTolog in Patients With Solid Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity
- Status
- COMPLETED
- Phase
- PHASE2
Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PD-1 Knockout Engineered T Cells for Castration Resistant Prostate Cancer
- Status
- WITHDRAWN
- Phase
- N/A
PD-1 Knockout Engineered T Cells for Metastatic Renal Cell Carcinoma.
- Status
- WITHDRAWN
- Phase
- PHASE1
Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PD-1 Knockout Engineered T Cells for Muscle-invasive Bladder Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
EDOCH Alternating With DHAP for New Diagnosed Younger MCL
- Status
- COMPLETED
- Phase
- PHASE4